58 studies found for:    Open Studies | "Adenoviridae Infections"
Show Display Options
Rank Status Study
21 Unknown  Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer
Condition: Non-Small Cell Lung Cancer
Interventions: Biological: Recombinant DNA- pVAX/L523S;   Biological: Recombinant adenovirus- Ad/L523S
22 Recruiting MG1 Maraba/MAGE-A3, With and Without Adenovirus Vaccine, With Transgenic MAGE-A3 Insertion in Patients With Incurable MAGE-A3-Expressing Solid Tumours
Condition: Advanced/Metastatic Solid Tumours
Interventions: Biological: MG1MA3;   Biological: AdMA3
23 Recruiting Residual Sample Collection for Respiratory Viral Panel
Condition: Respiratory Viral Illnesses: Influenza A/B, RSV, Adenovirus
Intervention:
24 Recruiting Safety, Tolerability, and Immunogenicity of the Ebola Chimpanzee Adenovirus Vector Vaccine (cAd3-EBO), VRC-EBOADC069-00-VP, in Healthy Adults
Condition: Healthy Adult Immune Responses to Vaccine
Interventions: Biological: VRC-EBOADC069-00-VP;   Biological: VRC-EBOADC076-00-VP
25 Recruiting Anti-virus Treatment Following Bone Marrow Transplant
Conditions: Allogeneic Stem Cell Transplant;   Viral Infection;   Viral Reactivation
Intervention: Biological: Viral specific CTL Infusion
26 Available Allogeneic Virus-Specific Cytotoxic T-Lymphocytes(CTL), Persistent/Recurrent Viral Infection Post-HSCT (EAP CHALLAH)
Conditions: EBV Infection;   CMV Infection;   Adenoviral Infection
Intervention: Biological: Trivirus-Specific CTLs
27 Recruiting Multivirus-specific T Cells for the Treatment of Virus Infections After Stem Cell Transplant
Condition: Infection
Intervention: Biological: Multivirus Specific T cells
28 Recruiting A Phase I Study of an HIV Vaccine in Healthy, HIV Uninfected Adults
Condition: Healthy
Interventions: Biological: MVA Mosaic;   Biological: Placebo
29 Recruiting DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors
Conditions: Glioblastoma;   Gliosarcoma
Interventions: Drug: Single intratumoral injection of DNX-2401;   Drug: interferon gamma
30 Not yet recruiting ADenoVirus Initiative Study in Epidemiology in UK
Condition: Viral Conjunctivitis
Intervention:
31 Recruiting ADenoVirus Initiative Study in Epidemiology in Spain
Condition: Viral Conjunctivitis
Intervention:
32 Recruiting ADenoVirus Initiative Study in Epidemiology in Germany
Condition: Viral Conjunctivitis
Intervention:
33 Recruiting Study of a Recombinant Adenovirus to Treat Localized Prostate Cancer
Condition: Localized Prostate Cancer
Intervention: Drug: Ad5-SGE-REIC/Dkk3
34 Recruiting Non-investigational Study to Evaluate Adenovirus Serotype 5 (Ad5) Neutralizing Antibodies (nAb) in Patients With Chronic Hepatitis B Virus (HBV) Mono-infection
Condition: Chronic Hepatitis B
Intervention: Other: blood draw
35 Unknown  Trial of E10A in Head and Neck Cancer
Conditions: Head and Neck Squamous Carcinoma;   Nasopharyngeal Carcinoma
Interventions: Drug: E10A;   Drug: Cisplatin;   Drug: Paclitaxel
36 Recruiting Virus DNX2401 and Temozolomide in Recurrent Glioblastoma
Conditions: Glioblastoma Multiforme;   Recurrent Tumor
Intervention: Procedure: DNX2401 and Temozolomide
37 Recruiting Trial of the Safety and Immunogenicity of an Oral, Replicating Ad26 Vectored HIV-1 Vaccine
Condition: HIV
Interventions: Biological: rcAd26.MOS1.HIV-Env 1x10^8 vp;   Biological: rcAd26.MOS1.HIV-Env 1x10^9 vp;   Biological: rcAd26.MOS1.HIV-Env 1x10^10 vp;   Biological: rcAd26.MOS1.HIV-Env 1x10^11 vp
38 Recruiting A Phase I Dose Escalation Study of Intravenous VCN-01 With or Without Gemcitabine in Patients With Advanced Solid Tumors
Conditions: Locally Advanced Solid Tumors;   Metastatic Solid Tumors
Interventions: Genetic: VCN-01;   Drug: Gemcitabine
39 Recruiting A Phase I Dose Escalation Study of Intratumoral VCN-01 Injections With or Without Gemcitabine in Patients With Advanced Pancreatic Cancer
Conditions: Locally Advanced Pancreatic Adenocarcinoma;   Metastatic Pancreatic Adenocarcinoma
Interventions: Genetic: VCN-01;   Drug: Gemcitabine
40 Recruiting Mechanism of Action Trial of ColoAd1
Conditions: Resectable Colon Cancer;   Resectable Non-small Cell Lung Cancer;   Resectable Bladder Cancer;   Resectable Renal Cell Carcinoma
Intervention: Biological: Colo-Ad1

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-58) Show next page of results    Last Page
Indicates status has not been verified in more than two years